Literature DB >> 11361908

Cognitive impairment in school-age children with asymptomatic HIV infection.

C Fundarò1, N Miccinesi, N F Baldieri, O Genovese, C Rendeli, G Segni.   

Abstract

Previous studies have shown that there is a positive correlation between clinical expression of HIV-1 disease and deficits in the cognitive and neuropsychologic abilities in afflicted children. To date there are few studies regarding analysis of the cognitive and neuropsychologic development of HIV-positive, asymptomatic nonprogressor children (6-12 years of age) (long-survivors). The purpose of this study was to explore the differences in neuropsychologic development of asymptomatic HIV-positive school-age children compared with a seroreverted group. Evaluation was conducted in 8 children with asymptomatic or mild clinical signs of HIV infection compared with 8 seroreverted children. All tests were administered in three sessions by a trained specialist in neuropsychologic observation. The results of neuropsychologic testing suggested the presence of some learning disorders, as well as major memory and perception deficit. Most of the children tended to have levels of performance that were below normal values. The impairment could likely be the expression of a greater biologic vulnerability of HIV-positive children. Additional studies are necessary to define the risk factors and, hence, the protective factors that might support normal development of HIV-positive children.

Entities:  

Mesh:

Year:  1998        PMID: 11361908     DOI: 10.1089/apc.1998.12.135

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  8 in total

1.  A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naïve "slow progressors".

Authors:  Jacqueline Hoare; Jean-Paul Fouche; Bruce Spottiswoode; Kirsty Donald; Nicole Philipps; Heidre Bezuidenhout; Christine Mulligan; Victoria Webster; Charity Oduro; Leigh Schrieff; Robert Paul; Heather Zar; Kevin Thomas; Dan Stein
Journal:  J Neurovirol       Date:  2012-05-03       Impact factor: 2.643

2.  Learning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure.

Authors:  Sharon L Nichols; Miriam C Chernoff; Kathleen Malee; Patricia A Sirois; Paige L Williams; Veronica Figueroa; Steven P Woods
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

3.  Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease.

Authors:  Sanneke Koekkoek; Laura Eggermont; Leo De Sonneville; Thidakat Jupimai; Saijai Wicharuk; Wichitea Apateerapong; Theshinee Chuenyam; Joep Lange; Ferdinand Wit; Chitsanu Pancharoen; Praphan Phanuphak; Jintanat Ananworanich
Journal:  J Neurol       Date:  2006-11-08       Impact factor: 4.849

Review 4.  Neurodevelopment: The Impact of Nutrition and Inflammation During Early to Middle Childhood in Low-Resource Settings.

Authors:  Chandy C John; Maureen M Black; Charles A Nelson
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 5.  HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis.

Authors:  Nicole Phillips; Taryn Amos; Caroline Kuo; Jacqueline Hoare; Jonathan Ipser; Kevin G F Thomas; Dan J Stein
Journal:  Pediatrics       Date:  2016-10-11       Impact factor: 7.124

6.  Designing and evaluating Brain Powered Games for cognitive training and rehabilitation in at-risk African children.

Authors:  B Giordani; B Novak; A Sikorskii; P Bangirana; N Nakasujja; B M Winn; M J Boivin
Journal:  Glob Ment Health (Camb)       Date:  2015-05-29

7.  Cognitive Deficits in HIV Infected Children.

Authors:  O S Ravindran; Mrudula P Rani; G Priya
Journal:  Indian J Psychol Med       Date:  2014-07

8.  The Value of a Motor Intervention for 3 to 6-Year-Old Children Infected with and Affected by HIV.

Authors:  Anita Elizabeth Pienaar; Jo-Anne Elizabeth Botha
Journal:  Int J Environ Res Public Health       Date:  2022-03-03       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.